Serum amyloid A (SAA) is an example of the biomarkers and effectors of obesity-related inflammation, and it is involved in the mechanisms of lipid metabolism, atherosclerosis and acute phase response besides inflammation [56,57]. This evidence concerns the gene SAA2 and obesity due to melanocortin 4 receptor deficiency.